Insights

MSO and Pharmacy Leverage Generex’s integrated MSO network and pharmacy footprint through NuGenerex Distribution Solutions to cross-sell diagnostic services, durable medical equipment, and personalized therapies to physician groups and patients across the network.

Diagnostics and Labs Target the company’s clinical laboratory capabilities and DME-IQ assets to offer expanded testing panels, rapid diagnostics, and remote patient monitoring solutions that enhance the value proposition for physician partners and payers.

Biotech Assets Position immune-oncology assets and Ii-Key vaccine platforms for strategic partnerships, licensing deals, or co-development with pharma companies seeking mid-stage assets to accelerate clinical programs.

SaaS RPM Exploit the NuGenHealth SaaS program to upsell digital health and RPM services to existing clients, creating recurring revenue opportunities and improve patient engagement metrics used in value-based care contracts.

Public Funding Monitor and align with ongoing fundraising and potential IPO activity to time partnerships and co-investment opportunities, leveraging investor interest to secure joint ventures, grant-funded programs, or milestone-based collaborations.

Similar companies to Generex Biotechnology Corporation

Generex Biotechnology Corporation Tech Stack

Generex Biotechnology Corporation uses 1 technology products and services including reCAPTCHA, and more. Explore Generex Biotechnology Corporation's tech stack below.

  • reCAPTCHA
    Security

Media & News

Generex Biotechnology Corporation's Email Address Formats

Generex Biotechnology Corporation uses at least 3 email formats:
Generex Biotechnology Corporation Email FormatsExamplePercentage
FLast@generex.comJDoe@generex.com
62%
Last@generex.comDoe@generex.com
24%
LFirst@generex.comDJohn@generex.com
14%

Frequently Asked Questions

What is Generex Biotechnology Corporation's phone number?

Minus sign iconPlus sign icon
You can contact Generex Biotechnology Corporation's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Generex Biotechnology Corporation's official website and social media links?

Minus sign iconPlus sign icon
Generex Biotechnology Corporation's official website is generex.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Generex Biotechnology Corporation generate?

Minus sign iconPlus sign icon
As of October 2026, Generex Biotechnology Corporation's annual revenue is estimated to be $1M - $10M.

What is Generex Biotechnology Corporation's SIC code and NAICS code?

Minus sign iconPlus sign icon
Generex Biotechnology Corporation's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Generex Biotechnology Corporation have currently?

Minus sign iconPlus sign icon
As of October 2026, Generex Biotechnology Corporation has approximately 20 employees across 4 continents, including North America, Asia and Europe. Key team members include Chief Operating Officer: D. B., Director: L. B. and Logistics Manager: K. M. Explore Generex Biotechnology Corporation's employee directory with LeadIQ.

What industry does Generex Biotechnology Corporation belong to?

Minus sign iconPlus sign icon
Generex Biotechnology Corporation operates in the Biotechnology Research industry.

What technology does Generex Biotechnology Corporation use?

Minus sign iconPlus sign icon
Generex Biotechnology Corporation's tech stack includes reCAPTCHA.

What is Generex Biotechnology Corporation's email format?

Minus sign iconPlus sign icon
Generex Biotechnology Corporation's email format typically follows the pattern of FLast@generex.com. Find more Generex Biotechnology Corporation email formats with LeadIQ.

How much funding has Generex Biotechnology Corporation raised to date?

Minus sign iconPlus sign icon
As of October 2026, Generex Biotechnology Corporation has raised $9.4M in funding. The last funding round occurred on Aug 10, 2012 for $750K.
Generex Biotechnology Corporation logo

Generex Biotechnology Corporation

Biotechnology ResearchFlorida, United States11-50 Employees

Generex Biotechnology Corporation is a biotechnology research company located at 10102 Usa Today Way Suite 200, Miramar, Florida 33025, United States, with 11 to 50 employees. It operates as an integrated healthcare holding company delivering end-to-end patient centric care, spanning rapid diagnosis to the delivery of personalized therapies. The company supports physicians through a managed services organization network and maintains ongoing relationships with patients to improve access to care. Generex maintains a legacy portfolio of immune-oncology assets, medical devices, and diagnostics and pursues an acquisition strategy to complement existing assets and provide revenue sources; recent acquisitions include a management services organization, a network of pharmacies, a clinical laboratory, and medical device companies. Its wholly owned subsidiary NuGenerex Distribution Solutions integrates the MSO network with a pharmacy network, a clinical diagnostic lab, a durable medical equipment company, and a dedicated call center.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $9.4M

    Generex Biotechnology Corporation has raised a total of $9.4M of funding over 4 rounds. Their latest funding round was raised on Aug 10, 2012 in the amount of $750K as a Post IPO Equity.

  • $1M - $10M

    Generex Biotechnology Corporation's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.